The role of the microbiome in NAFLD and NASH
Abstract Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of cardiometabolic syndrome, which often also includes obesity, diabetes, and dyslipidemia. It is rapidly becoming the most prevalent liver disease worldwide. A sizable minority of NAFLD patients develop nonalcoholic stea...
Main Authors: | Aleksandra A Kolodziejczyk, Danping Zheng, Oren Shibolet, Eran Elinav |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2019-02-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201809302 |
Similar Items
-
Noninvasive Diagnosis of NAFLD and NASH
by: Valeria Annarita Piazzolla, et al.
Published: (2020-04-01) -
Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery
by: Marielle Malucelli, et al.
Published: (2023-11-01) -
Current Options and Future Directions for NAFLD and NASH Treatment
by: Chunye Zhang, et al.
Published: (2021-07-01) -
Deciphering the role of aberrant DNA methylation in NAFLD and NASH
by: Meenakshi Vachher, et al.
Published: (2022-10-01) -
Artificial Intelligence in NAFLD: Will Liver Biopsy Still Be Necessary in the Future?
by: Lei Zhang, et al.
Published: (2022-12-01)